Norafin looks back at a long and successful history. At the beginning of the 1980s, the company developed the first line of spunlace products in Europe in conjunction with the research institute for the textile industry, today's STFI. This was a milestone not only for Norafin in its corporate development, but also pioneering for the entire industry. Because of the structural quality of the line as well as the company's own expertise, Norafin soon focused on the development of technical nonwovens and special applications.
Today, the company is known for its customer-oriented product solutions in the field of process air and liquid filtration as well as for its nonwoven product concepts and engineered fabrics for the protective clothing, medical and construction industries. The development of new composites is moving on. Norafin applies its own spunlace and needlepunch technology to create its customized materials.
In Spring 2016, a new investment company acquires the majority of Norafin and allows the company to grow further.
Norafin separates from Vernal. Norafin continues with its successful niche strategy with the help of an investor and continues to provide high-quality.
The STA Group is fully separated from Jacob Holm. The name of the holding changes from Jacob Holm & Sons STA to Vernal.
Expansion of the Jacob Holm Group by the acquisition of Tytex, a leading producer of advanced textiles in the healthcare market and by the spin-off of
Integration of Norafin into the Jacob Holm Group; further development of the technical and speciality applications business unit.
1997 & 1998
Erection of Norafin's new spunlace and needlepunch facility in Mildenau, Germany.
Start of operation in Wiesenbad (near Chemnitz), Germany, to produce compresses as well as technical nonwovens for the synthetic leather and electrica
Development of the first spunlace line in Europe in cooperation with the Saxon research institute for textile industry.